Reaction
Leiomyosarcoma reporting signals
As of the last recalculation, Leiomyosarcoma appears in 381 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 52.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 11 | 52.6 | 52.6 |
| Pazopanib Hydrochloride | 22 | 47.1 | 47.1 |
| Gemcitabine | 16 | 23.1 | 23.1 |